Debbie L. Hardie
- Immunology top 5%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Oncology
- Rheumatology top 10%
- Co-authors
- Christopher D. BuckleyN. R. LingJ. LoweR JefferisP BirdAndrew FilerI. C. M. MaclennanMike Salmon
- Topics
- Monoclonal and Polyclonal Antibodies Research (14 papers)T-cell and B-cell Immunology (9 papers)Glycosylation and Glycoproteins Research (8 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Debbie L. Hardie
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 85
- Immunology 603
- Molecular Biology 320
- Radiology, Nuclear Medicine and Imaging 272
- Oncology 232
- Rheumatology 141
Countries citing papers authored by Debbie L. Hardie
This map shows the geographic impact of Debbie L. Hardie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie L. Hardie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie L. Hardie more than expected).
Fields of papers citing papers by Debbie L. Hardie
This network shows the impact of papers produced by Debbie L. Hardie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie L. Hardie. The network helps show where Debbie L. Hardie may publish in the future.
Co-authorship network of co-authors of Debbie L. Hardie
This figure shows the co-authorship network connecting the top 25 collaborators of Debbie L. Hardie. A scholar is included among the top collaborators of Debbie L. Hardie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debbie L. Hardie. Debbie L. Hardie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | 83 | |
| 3 | 42 | |
| 4 | 33 | |
| 5 | 89 | |
| 6 | 35 | |
| 7 | 13 | |
| 8 | 69 | |
| 9 | 41 | |
| 10 | 80 | |
| 11 | 98 | |
| 12 | 7 | |
| 13 | 21 | |
| 14 | 4 | |
| 15 | 5 | |
| 16 | 9 | |
| 17 | 47 | |
| 18 | 4 | |
| 19 | 36 | |
| 20 | Use of monoclonal antibodies reactive with secretory epithelial cells for the immunocytochemical identification of plasma cells | 3 |
About Debbie L. Hardie
Debbie L. Hardie is a scholar working on Immunology, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), T-cell and B-cell Immunology (9 papers) and Glycosylation and Glycoproteins Research (8 papers). The work is most often cited by research in Immunology (603 citations), Immunology and Allergy (97 citations) and Hematology (135 citations). Debbie L. Hardie has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Christopher D. Buckley, N. R. Ling, J. Lowe, R Jefferis, P Bird, Andrew Filer, I. C. M. Maclennan, Mike Salmon, Oliver Haworth and David Adams. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.